Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion type Assertion NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_head.
- NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion description "[In tissue sections, cells with high expression of insulin-like growth factor II were observed not only in hepatocellular carcinoma (93%) but also in 95% of the pericancerous liver tissues, 72% of cirrhotic livers, 64% of chronic active hepatitis and 37% of chronic persistent hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_provenance.
- NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion evidence source_evidence_literature NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_provenance.
- NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion SIO_000772 7927218 NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_provenance.
- NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion wasDerivedFrom befree-20140225 NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_provenance.
- NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_assertion wasGeneratedBy ECO_0000203 NP311880.RAVKjd6TfdGjFYWbsGdq-RBSh9gk2MwU-oX2ZQpM_xilU130_provenance.